β2-Adrenoceptor-mediated regulation of glucose uptake in skeletal muscle - Ligand-directed signalling or a reflection of system complexity?

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 386, Issue 9, 2013, Pages 757-760

  Evans, Bronwyn A ^a   Hutchinson, Dana S ^a   Summers, Roger J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA 2 ADRENERGIC RECEPTOR; CLENBUTEROL; G PROTEIN COUPLED RECEPTOR; GLUCOSE; ROLIPRAM;

GLUCOSE TRANSPORT; NONHUMAN; REVIEW; SKELETAL MUSCLE;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANIMALS; GLUCOSE; LIGANDS; MUSCLE, SKELETAL; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 84883228610     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-013-0879-7     Document Type: Review

References (34)

1. Allen JA, Yost JM, Setola V, Chen X, Sassano MF, Chen M et al (2011) Discovery of beta-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc Natl Acad Sci U S A 108(45):18488-18493
2. Appleton KM, Lee MH, Alele C, Luttrell DK, Peterson YK, Morinelli TA et al (2013) Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity. Methods Enzymol 522:229-262
3. Baker JG (2010) The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors. Br J Pharmacol 160(5):1048-1061
4. Baker JG, Hall IP, Hill SJ (2003) Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses. Mol Pharmacol 64(3):679-688
5. Baker JG, Kemp P, March J, Fretwell L, Hill SJ, Gardiner SM (2011) Predicting in vivo cardiovascular properties of beta-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses. FASEB J 25(12):4486-4497
6. Blattermann S, Peters L, Ottersbach PA, Bock A, Konya V, Weaver CD et al (2012) A biased ligand for OXE-R uncouples Galpha and Gbetagamma signaling within a heterotrimer. Nat Chem Biol 8(7):631-638
7. Busnelli M, Sauliere A, Manning M, Bouvier M, Gales C, Chini B (2012) Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes. J Biol Chem 287(6):3617-3629
8. DeWire SM, Yamashita DS, Rominger DH, Liu G, Cowan CL, Graczyk TM et al (2013) A G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J Pharmacol Exp Ther 344(3):708-717
9. Duarte T, Menezes-Rodrigues FS, Godinho RO (2012) Contribution of the extracellular cAMP-adenosine pathway to dual coupling of beta2-adrenoceptors to Gs and Gi proteins in mouse skeletal muscle. J Pharmacol Exp Ther 341(3):820-828
10. Emery AC, DiRaddo JO, Miller E, Hathaway HA, Pshenichkin S, Takoudjou GR et al (2012) Ligand bias at metabotropic glutamate 1a receptors: molecular determinants that distinguish beta-arrestin-mediated from G protein-mediated signaling. Mol Pharmacol 82(2):291-301
11. Evans BA, Broxton N, Merlin J, Sato M, Hutchinson DS, Christopoulos A et al (2011) Quantification of functional selectivity at the human alpha(1A)-adrenoceptor. Mol Pharmacol 79(2):298-307
12. Evans BA, Sato M, Sarwar M, Hutchinson DS, Summers RJ (2010) Ligand-directed signalling at beta-adrenoceptors. Br J Pharmacol 159(5):1022-1038
13. Galandrin S, Oligny-Longpre G, Bonin H, Ogawa K, Gales C, Bouvier M (2008) Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta1-adrenergic receptor. Mol Pharmacol 74(1):162-172
14. Gregory KJ, Sexton PM, Tobin AB, Christopoulos A (2012) Stimulus bias provides evidence for conformational constraints in the structure of a G protein-coupled receptor. J Biol Chem 287(44):37066-37077
15. Kahsai AW, Xiao K, Rajagopal S, Ahn S, Shukla AK, Sun J et al (2011) Multiple ligand-specific conformations of the beta2-adrenergic receptor. Nat Chem Biol 7(10):692-700
16. Kenakin T (2011) Functional selectivity and biased receptor signaling. J Pharmacol Exp Ther 336(2):296-302
17. Kenakin T, Christopoulos A (2012) Signalling bias in new drug discovery: detection, quantification and therapeutic impact. Nat Rev Drug Discov 12(3):205-216
18. Kenakin T, Miller LJ (2010) Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev 62(2):265-304
19. Kenakin T, Watson C, Muniz-Medina V, Christopoulos A, Novick S (2012) A simple method for quantifying functional selectivity and agonist bias. ACS Chem Neurosci 3(3):193-203
20. Liu JJ, Horst R, Katritch V, Stevens RC, Wuthrich K (2012) Biased signaling pathways in beta2-adrenergic receptor characterized by 19F-NMR. Science 335(6072):1106-1110
21. Mary S, Damian M, Louet M, Floquet N, Fehrentz JA, Marie J et al (2012) Ligands and signaling proteins govern the conformational landscape explored by a G protein-coupled receptor. Proc Natl Acad Sci U S A 109(21):8304-8309
22. Ngala RA, O'Dowd J, Wang SJ, Agarwal A, Stocker C, Cawthorne MA et al (2008) Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and beta2-adrenoceptor mechanisms. Br J Pharmacol 155(3):395-406
23. Ngala RA, O'Dowd J, Wang SJ, Stocker C, Cawthorne MA, Arch JR (2009) Beta2-adrenoceptors and non-beta-adrenoceptors mediate effects of BRL37344 and clenbuterol on glucose uptake in soleus muscle: studies using knockout mice. Br J Pharmacol 158(7):1676-1682
24. 2-adrenoceptor agonists can both stimulate and inhibit glucose uptake in mouse soleus muscle through ligand-directed signalling. Naunyn Schmiedebergs Arch Pharmacol. doi: 10.1007/s00210-013-0860-5
25. Nijmeijer S, Vischer HF, Rosethorne EM, Charlton SJ, Leurs R (2012) Analysis of multiple histamine H(4) receptor compound classes uncovers Galphai protein- and beta-arrestin2-biased ligands. Mol Pharmacol 82(6):1174-1182
26. Pradhan AA, Walwyn W, Nozaki C, Filliol D, Erbs E, Matifas A et al (2010) Ligand-directed trafficking of the delta-opioid receptor in vivo: two paths toward analgesic tolerance. J Neurosci 30(49):16459-16468
27. Rajagopal S, Ahn S, Rominger DH, Gowen-MacDonald W, Lam CM, Dewire SM et al (2011) Quantifying ligand bias at seven-transmembrane receptors. Mol Pharmacol 80(3):367-377
28. Sato M, Horinouchi T, Hutchinson DS, Evans BA, Summers RJ (2007) Ligand-directed signaling at the beta3-adrenoceptor produced by 3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) relative to receptor agonists. Mol Pharmacol 72(5):1359-1368
29. Sato M, Hutchinson DS, Evans BA, Summers RJ (2008) The beta3-adrenoceptor agonist 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4- hydroxyphenoxy)propyl]amino]ethyl]-phenyl]-benzenesulfonamide (L755507) and antagonist (S)-N-[4-[2-[[3-[3-(acetamidomethyl)phenoxy]-2-hydroxypropyl]amino]- ethyl]phenyl] benzenesulfonamide (L748337) activate different signaling pathways in Chinese hamster ovary-K1 cells stably expressing the human beta3-adrenoceptor. Mol Pharmacol 74(5):1417-1428
30. Stallaert W, Christopoulos A, Bouvier M (2011) Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors. Expert Opin Drug Discov 6(8):811-825
31. Tschammer N, Bollinger S, Kenakin T, Gmeiner P (2011) Histidine 6.55 is a major determinant of ligand-biased signaling in dopamine D2L receptor. Mol Pharmacol 79(3):575-585
32. Violin JD, DeWire SM, Yamashita D, Rominger DH, Nguyen L, Schiller K et al (2010) Selectively engaging beta-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance. J Pharmacol Exp Ther 335(3):572-579
33. Woo AY, Wang TB, Zeng X, Zhu W, Abernethy DR, Wainer IW et al (2009) Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes. Mol Pharmacol 75(1):158-165
34. Wootten D, Simms J, Miller LJ, Christopoulos A, Sexton PM (2013) Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations. Proc Natl Acad Sci U S A 110(13):5211-5216